| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/17/1996 | EP0441900B1 Natural killer stimulatory factor |
| 07/17/1996 | EP0408625B1 Diagnosis of mycobacterium bovis infection |
| 07/17/1996 | CN1127000A Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis |
| 07/17/1996 | CN1126761A DNA sequences encoding novel biosynthetic insulin precursors and process for preparation of insulin |
| 07/17/1996 | CN1126759A Expression systems utilizing autolyzing fusion proteins and a novel reducing polypeptide |
| 07/17/1996 | CN1032315C Method for producing hepatitis B virus proteins in yeast |
| 07/16/1996 | US5536814 Integrin-binding peptides |
| 07/16/1996 | US5536812 Calcitonin analogue and use thereof |
| 07/16/1996 | US5536657 Recombinant DNA encoding human receptor for interleukin-12 |
| 07/16/1996 | US5536652 L-phenylalanyl-tRNA synthetase mutants, a process for the preparation thereof and the use thereof for the in vivo incorporation of non-proteinogenous amino acids into peptides or proteins |
| 07/16/1996 | US5536647 Nucleic acids and vector encoding HMFQ polypeptide, transfected host, fusion proteins thereof, compositions thereof and methods of use thereof |
| 07/16/1996 | US5536641 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1 and uses thereof for detection of, and isolation of, vascular endothelial cells |
| 07/16/1996 | US5536639 Methods for detecting calpain activation by detection of calpain activated spectrin breakdown products |
| 07/16/1996 | US5536637 Method of screening for cDNA encoding novel secreted mammalian proteins in yeast |
| 07/16/1996 | US5536497 Fimbrial polypeptides useful in the prevention of periodontitis |
| 07/16/1996 | US5536496 Pasteurella multocida toxoid vaccines |
| 07/16/1996 | CA2034489C Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions |
| 07/11/1996 | WO1996021155A1 Peptide reagent for detecting a primary epstein-barr virus infection by testing for the corresponding antibodies, and method for using same |
| 07/11/1996 | WO1996021043A1 Using lambdoid bacteriophages linked by oligonucleotides to solid support |
| 07/11/1996 | WO1996021035A2 Retroviral delivery of full length factor viii |
| 07/11/1996 | WO1996021034A1 Avian recombinant live vaccine |
| 07/11/1996 | WO1996021032A1 Transgenic plants exhibiting heterologous virus resistance |
| 07/11/1996 | WO1996021031A1 Transgenic plants expressing dna constructs containing a plurality of genes to impart virus resistance |
| 07/11/1996 | WO1996021030A1 Enhanced accumulation of trehalose in plants |
| 07/11/1996 | WO1996021029A1 Oil body proteins as carriers of high value proteins |
| 07/11/1996 | WO1996021028A2 Soluble heterodimeric t cell receptors and their antibodies |
| 07/11/1996 | WO1996021020A2 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases |
| 07/11/1996 | WO1996021019A1 Papaya ringspot virus coat protein gene |
| 07/11/1996 | WO1996021018A1 Plants resistant to c strains of cucumber mosaic virus |
| 07/11/1996 | WO1996021016A2 New staphylokinase derivatives |
| 07/11/1996 | WO1996021015A2 Combination gene delivery vehicles |
| 07/11/1996 | WO1996021014A2 Production and administration of high titer recombinant retroviruses |
| 07/11/1996 | WO1996021013A1 Methods for diagnosis and treatment of mdk1 signal transduction disorders |
| 07/11/1996 | WO1996021012A1 Methods for producing immunoglobulins containing protection proteins in plants and their use |
| 07/11/1996 | WO1996021011A2 PEPTIDES SPECIFIC FOR THE FIRST Crk-SH3 DOMAIN |
| 07/11/1996 | WO1996021007A2 Bacteriophage-mediated gene transfer systems capable of transfecting eukaryotic cells |
| 07/11/1996 | WO1996021006A1 Novel phosphoprotein secreted in the extracellular matrices of mammalian organs and methods for use thereof |
| 07/11/1996 | WO1996021001A1 Stabilization of blood platelets against low temperature activation |
| 07/11/1996 | WO1996021000A2 Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders |
| 07/11/1996 | WO1996020957A1 Anti-inflammatory cd14 polypeptides |
| 07/11/1996 | WO1996020956A1 Anti-inflammatory cd14 peptides |
| 07/11/1996 | WO1996020955A1 Purified thrombopoietin and method of making it |
| 07/11/1996 | WO1996020954A2 Functionally active domains of signal transducer and activators of transcription (stat) proteins |
| 07/11/1996 | WO1996020953A2 Synthetic multimeric peptide with delta hepatitis virus antigenic activity |
| 07/11/1996 | WO1996020951A1 Chimeric dna-binding proteins |
| 07/11/1996 | WO1996020950A2 Compositions and methods for treating rheumatoid arthritis |
| 07/11/1996 | WO1996020732A2 Non-traumatic administration of gene delivery vehicles |
| 07/11/1996 | WO1996020731A1 Direct administration of gene delivery vehicles at multiple sites |
| 07/11/1996 | WO1996020724A1 Generation of human insulin |
| 07/11/1996 | WO1996020723A1 Controlling traf-mediated signals |
| 07/11/1996 | WO1996020722A1 Compounds that inhibit t cell proliferation and methods using the same |
| 07/11/1996 | WO1996020721A1 Programmed cell death genes and proteins |
| 07/11/1996 | WO1996020717A1 Compositions and methods for inhibiting fungal cell wall formation |
| 07/11/1996 | WO1996020695A1 Prevention of leakage during thermotropic phase transition in liposomes and biological cells |
| 07/11/1996 | WO1996020688A2 Triggered pore-forming agents |
| 07/11/1996 | WO1996020611A1 Novel bioemulsifiers |
| 07/11/1996 | WO1996015758A3 Methods for stimulating erythropoiesis using thrombopoietin |
| 07/11/1996 | WO1996013608A3 Polynucleic acid sequences for use in the detection and differentiation of prokaryotic organisms |
| 07/11/1996 | WO1996010635A3 Genes encoding signal recognition particle of aspergillus niger |
| 07/11/1996 | WO1996007745A3 Mycobacteria functional screening and/or expression vectors |
| 07/11/1996 | CA2209663A1 Compositions and methods for inhibiting fungal cell wall formation |
| 07/11/1996 | CA2209604A1 Functionally active domains of signal transducer and activators of transcription (stat) proteins |
| 07/11/1996 | CA2209526A1 Programmed cell death genes and proteins |
| 07/11/1996 | CA2209523A1 Quantitative detection of specific nucleic acid sequences using lambdoid bacteriophages linked by oligonucleotides to solid support |
| 07/11/1996 | CA2209183A1 Chimeric dna-binding proteins |
| 07/11/1996 | CA2208699A1 Anti-inflammatory cd14 polypeptides |
| 07/11/1996 | CA2208016A1 Anti-inflammatory cd14 peptides |
| 07/11/1996 | CA2207905A1 Prevention of leakage during thermotropic phase transition in liposomes and biological cells |
| 07/11/1996 | CA2207892A1 Stabilization of blood platelets against low temperature activation |
| 07/11/1996 | CA2207577A1 Purified thrombopoietin and method of making it |
| 07/11/1996 | CA2206479A1 New staphylokinase derivatives |
| 07/11/1996 | CA2205871A1 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases |
| 07/11/1996 | CA2184897A1 Novel bioemulsifiers |
| 07/10/1996 | EP0721013A1 New staphylokinase derivatives |
| 07/10/1996 | EP0721012A2 Hyaluronic acid mediated motility receptor (RHAMM) |
| 07/10/1996 | EP0720654A1 Novel proteins/polypeptides and cotransfection plasmids and live recombinant carriers therefor |
| 07/10/1996 | EP0720653A1 Tbp2 FRAGMENTS OF THE TRANSFERRINE RECEPTOR OF NEISSERIA MENINGITIDIS |
| 07/10/1996 | EP0720652A1 Receptor recognition factors, protein sequences and methods of use thereof |
| 07/10/1996 | EP0720651A1 Nucleic acids encoding merosin, merosin fragments and uses thereof |
| 07/10/1996 | EP0720650A1 Human metabotropic glutamate receptor subtypes (hmr4, hmr6, hmr7) and related dna compounds |
| 07/10/1996 | EP0720623A1 Monoclonal antibodies against leukocyte-specific g-protein-coupled receptors |
| 07/10/1996 | EP0720622A1 Interaction of t-cell receptors and antigen in autoimmune disease |
| 07/10/1996 | EP0720621A1 Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses |
| 07/10/1996 | EP0720618A1 Process for the purification of basic fibroblast growth factor |
| 07/10/1996 | EP0720614A1 Metal complexes with charged linker |
| 07/10/1996 | EP0720486A1 Peripheralization of hematopoietic stem cells |
| 07/10/1996 | EP0720484A1 Methods and products for controlling immune responses in mammals |
| 07/10/1996 | EP0720482A1 Prosaposin and cytokine-derived peptides as therapeutic agents |
| 07/10/1996 | EP0666929A4 Method of inhibiting replication of hyperproliferative cells. |
| 07/10/1996 | EP0628168A4 Method for modulating proopiomelanocortin synthesis in a mammal. |
| 07/10/1996 | EP0457888B1 Octapeptide analogs of somatostatin having threonine at the sixth position |
| 07/10/1996 | EP0370090B1 Immunogens and biologically active peptides derived from shared sequences from antigens and anti-idiotypic antibodies or antibodies specific for cellular receptors of the antigens |
| 07/10/1996 | CN1126494A Method for recombinant production of biologically active polypeptides |
| 07/10/1996 | CN1126492A Recombinant antigens from mumps virus and their use in vaccines |
| 07/10/1996 | CN1126489A New stromal cell lines from human bone marrow and their use |
| 07/10/1996 | CN1126477A Separation of proteins |
| 07/10/1996 | CN1126441A Amplification of the vitamin B12 uptake system using polymers |
| 07/10/1996 | CN1126436A Vitamin B12 mediated oral delivery systems for GCSF and EPO |
| 07/10/1996 | CN1126243A Heat tolerant phytases |
| 07/10/1996 | CN1126207A Polysubstituted 3-acylamino-5-phenyl-1,4-benzodiazepin-2-one derivatives, process for their preparation and the pharmaceutical compositions containing them |